Building upon our previous work showing that Notch primes IL1β expression in TNBC, these data provide mechanistic insight into how IL1β is further processed in this breast cancer subtype, leading to TAM recruitment, CTL exclusion, and tumor progression. This evidence concerns the gene IL1B and neoplasm.